Volume 129, Issue 3, Pages (September 2005)

Slides:



Advertisements
Similar presentations
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Epigenetic Signatures of Autism: Trimethylated H3K4.
Advertisements

Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Implication of SSAT by Gene Expression and Genetic.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Germline Epigenetic Regulation of KILLIN in Cowden.
MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma  Jinyan Du, Arlo J. Miller, Hans R. Widlund, Martin.
Volume 150, Issue 1, Pages (July 2016)
Stephen Lory, PhD, Jeffrey K. Ichikawa, PhD  CHEST 
Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors  Anita Muthukaruppan, Annette Lasham,
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens  Iris Babion, Barbara C. Snoek,
Detection of Rearrangements and Transcriptional Up-Regulation of ALK in FFPE Lung Cancer Specimens Using a Novel, Sensitive, Quantitative Reverse Transcription.
Tracking CD40 signaling during germinal center development
Microarray-Based Prediction of Tumor Response to Neoadjuvant Radiochemotherapy of Patients With Locally Advanced Rectal Cancer  Caroline Rimkus, Jan Friederichs,
Volume 131, Issue 3, Pages (September 2006)
Volume 133, Issue 6, Pages (December 2007)
Volume 137, Issue 1, Pages (July 2009)
Christos Sotiriou, Chand Khanna, Amir A
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma  Jun Wang, MD, PhD, Zhi Li, MD, PhD,
Volume 131, Issue 3, Pages (September 2006)
TGM2: A Cell Surface Marker in Esophageal Adenocarcinomas
Profiling of microdissected gastric epithelial cells reveals a cell type—specific response to Helicobacter pylori infection  Anne Mueller, D. Scott Merrell,
Volume 138, Issue 4, Pages (August 2009)
Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles  Yunao Liu, M.Sc., Kai-Fai Lee, Ph.D., Ernest H.Y.
Global Mapping of Human RNA-RNA Interactions
Volume 1, Issue 1, Pages (February 2002)
Array-CGH Reveals Recurrent Genomic Changes in Merkel Cell Carcinoma Including Amplification of L-Myc  Kelly G. Paulson, Bianca D. Lemos, Bin Feng, Natalia.
Volume 133, Issue 5, Pages (November 2007)
Accurate Molecular Characterization of Formalin-Fixed, Paraffin-Embedded Tissues by microRNA Expression Profiling  Anna E. Szafranska, Timothy S. Davison,
Volume 67, Issue 6, Pages (June 2005)
Volume 133, Issue 3, Pages (September 2007)
Integrated analysis of miRNA and mRNA during differentiation of human CD34+ cells delineates the regulatory roles of microRNA in hematopoiesis  Nalini.
by Gregory H. Underhill, David George, Eric G. Bremer, and Geoffrey S
Volume 128, Issue 5, Pages (May 2005)
Volume 144, Issue 5, Pages e4 (May 2013)
Volume 133, Issue 6, Pages (December 2007)
Volume 23, Issue 4, Pages (April 2018)
Molecular Classification of Renal Tumors by Gene Expression Profiling
Volume 119, Issue 1, Pages (July 2000)
Adrien Le Thomas, Georgi K. Marinov, Alexei A. Aravin  Cell Reports 
Volume 124, Issue 3, Pages (March 2003)
The Translational Landscape of the Mammalian Cell Cycle
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Volume 85, Issue 2, Pages (January 2014)
Gene-Expression Variation Within and Among Human Populations
Widespread Inhibition of Posttranscriptional Splicing Shapes the Cellular Transcriptome following Heat Shock  Reut Shalgi, Jessica A. Hurt, Susan Lindquist,
Volume 127, Issue 2, Pages (August 2004)
Edwards Allen, Zhixin Xie, Adam M. Gustafson, James C. Carrington  Cell 
Volume 6, Issue 1, Pages (January 2016)
Joseph Rodriguez, Jerome S. Menet, Michael Rosbash  Molecular Cell 
Volume 12, Issue 6, Pages (December 2003)
Phosphorylation of Serine 2 within the RNA Polymerase II C-Terminal Domain Couples Transcription and 3′ End Processing  Seong Hoon Ahn, Minkyu Kim, Stephen.
Daniel F. Tardiff, Scott A. Lacadie, Michael Rosbash  Molecular Cell 
Renata C. Gallagher, Birgit Pils, Mohammed Albalwi, Uta Francke 
A Broadly Conserved Pathway Generates 3′UTR-Directed Primary piRNAs
mRNA level as % relative to
Volume 5, Issue 4, Pages e4 (October 2017)
Volume 130, Issue 7, Pages (June 2006)
Volume 22, Issue 3, Pages (January 2018)
Volume 10, Issue 6, Pages (December 2006)
Volume 5, Issue 4, Pages e4 (October 2017)
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
Gene Expression Profiles of Cutaneous B Cell Lymphoma
Volume 21, Issue 9, Pages (November 2017)
Volume 122, Issue 6, Pages (September 2005)
Characterization of messenger RNA expression of estrogen receptor-α and -β in patients with ovarian endometriosis  Sachiko Matsuzaki, M.D., Takao Fukaya,
Brandon Ho, Anastasia Baryshnikova, Grant W. Brown  Cell Systems 
Blastocyst gene expression correlates with implantation potential
Qing-Rong Chen, Gordon Vansant, Kahuku Oades, Maria Pickering, Jun S
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
SUPT4H1 Depletion Leads to a Global Reduction in RNA
Volume 28, Issue 3, Pages e7 (July 2019)
Presentation transcript:

Volume 129, Issue 3, Pages 1047-1059 (September 2005) Defective DNA Mismatch Repair Determines a Characteristic Transcriptional Profile in Proximal Colon Cancers  Massimiliano di Pietro, Jacob Sabates Bellver, Mirco Menigatti, Fridolin Bannwart, Annelies Schnider, Anna Russell, Kaspar Truninger, Josef Jiricny, Giancarlo Marra  Gastroenterology  Volume 129, Issue 3, Pages 1047-1059 (September 2005) DOI: 10.1053/j.gastro.2005.06.028 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Unsupervised hierarchical clustering of normal colon mucosa and colon cancer samples based on analysis with the Affymetrix gene set after exclusion of unexpressed genes (see supplemental material online at www.gastrojournal.org). The 5858 probes plotted on the y-axis are color coded to indicate their expression levels relative to the median level for the gene across the entire sample set (blue, lower; red, higher). The 35 tissue samples represented on the x-axis include 10 normal mucosa samples (green bars), 12 MMR-deficient cancers (red bars), and 13 MMR-proficient cancers (blue bars). Gastroenterology 2005 129, 1047-1059DOI: (10.1053/j.gastro.2005.06.028) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Principal component analysis of the 25 proximal colon cancers and the 14 colon cancer cell lines. (See supplemental material online at www.gastrojournal.org for details on principal component analysis methodology.) (A) Normalized component-1 output values (y-axis, log-scale) for the 25 cancer specimens (x-axis, numbered as in Table 1). The difference between values for MMR-proficient and MMR-deficient cancers was highly significant (t = 4.70; P < .0001). (B) Unsupervised hierarchical clustering of the 25 cancers based on the component-1 gene set, that is, the 151 genes (160 probes) with significant principal component analysis values (greater than 0.7 and less than −0.7) in component 1. With 2 exceptions, MMR-proficient cancers 3 and 8 (red bars), the cancers formed 2 clusters that coincided with MMR-status subgroups. (C) Normalized component-2 output values (y-axis, log-scale) for the 25 cancers (x-axis, numbered as in Table 1). There was a highly significant difference between values for the lymph node–positive and lymph node–negative cancers (t = 5.27; P < .0001). (D) Component-1 and (E) component-2 output values (y-axes, log-scale) for the 14 colon cancer cell lines (x-axes). Components 1 and 2 accounted for 20% and 13%, respectively, of the total variance in the cell line data set. In both cases, MMR-deficient and MMR-proficient cell lines were distinguished by significantly different output values (component 1: t = 2.26, P = .043; component 2: t = 3.88, P = .0022). Gastroenterology 2005 129, 1047-1059DOI: (10.1053/j.gastro.2005.06.028) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 Supervised hierarchical clustering of colon cancers and colon cancer cell lines classified on the basis of their MMR status. (A) Clustering of 25 colon cancers by the MMR-status signature gene set (100 genes, 106 probes) shown in Table 3. (B) Clustering of 14 colon cancer cell lines by the 66 genes shown in Supplementary Table 2, which can be considered a cell line–specific version of the MMR-status signature set. (C) Clustering of colon cancers and cell lines by the MMR-related epithelial cell signature gene set shown in Table 4. Sample tree: MMR-proficient cell lines in light blue, MMR-proficient cancers in dark blue, MMR-deficient cell lines in orange, and MMR-deficient cancers in red. Gastroenterology 2005 129, 1047-1059DOI: (10.1053/j.gastro.2005.06.028) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 Selection of the MMR-related tumorigenesis signature gene set from the MMR-status signature gene set. (A) The light gray circle represents the 682 genes whose expression levels in MMR-deficient cancers were significantly increased or decreased, relative to those in normal mucosa (NM), with fold changes (FC) of ≥2.0. (The 10 normal mucosa samples were considered as a homogeneous group because their variability was much less marked than that observed among the cancer specimens, as shown in Figure 1). The white circle represents 759 genes displaying significantly altered expression (no FC restrictions) in MMR-proficient cancers with respect to normal mucosa. (Elimination of the FC cutoff in this selection allowed us to identify MMR-deficient–specific changes with greater accuracy.) The intersection of the 2 circles represents the 383 genes displaying similar alterations in MMR-deficient and MMR-proficient cancers with respect to normal mucosa. Exclusion of these genes leaves 299 genes whose expression was altered (relative to normal mucosa) exclusively in MMR-deficient cancers. (B) A similar procedure was used to identify 190 genes with significant expression changes (relative to normal mucosa) that were confined exclusively to MMR-proficient cancers. (C) The light gray circles here represent the sets of 299 and 190 genes obtained in A and B, while the dark gray circle represents the 100 genes making up the MMR-status signature (Table 3). Gene set characteristics in terms of differences between transcriptional levels in MMR-deficient cancers, MMR-proficient cancers, and normal mucosa are summarized in the small rectangles; differences are classified as significant (S) or nonsignificant (NS). Overlap between the light gray circle on the left and the dark gray circle represents 21 genes whose expression levels in MMR-deficient cancers were significantly different (FC ≥2.0) from those observed in normal mucosa and also significantly different from those of MMR-proficient cancers. Intersection of the dark gray circle and the light gray circle on the right defines 18 other genes with expression levels in MMR-proficient cancers that differed significantly (FC ≥2.0) from those of normal mucosa and also from those of MMR-deficient cancers. These 39 genes represent a subset of the MMR-status signature gene set, which we refer to as the MMR-related tumorigenesis signature. Gastroenterology 2005 129, 1047-1059DOI: (10.1053/j.gastro.2005.06.028) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 5 4-1BBL messenger RNA (mRNA) and protein expression in MMR-deficient and MMR-proficient colon cancer cell lines. (No data are shown for 5 of the cell lines, which could not be reliably analyzed with flow cytometry.) (A) Gray bars represent mRNA levels based on raw signals (y-axis) detected in MMR-deficient (x-axis; left) and MMR-proficient (x-axis; right) cell lines with the Affymetrix U95v2 microarray. (B) Gray bars represent mRNA levels for the 4-1BBL coding region in MMR-deficient (left) and MMR-proficient (right) cell lines determined by quantitative reverse-transcription polymerase chain reaction (RT-PCR); white bars represent corresponding levels for amplification of the control housekeeping gene GAPDH. The 4-1BBL coding region was amplified with primers complementary to the exon 2/exon 3 boundary (forward) and to the central region of exon 3 (reverse). The number of cycles (y-axis) at the beginning of the log-phase amplification is inversely correlated with the abundance of the transcript. (C) Gray bars represent cytoplasmic membrane expression of 4-1BBL polypeptide assessed by flow cytometry. Jurkat and Raji cells (white bars) were used as negative and positive controls, respectively, and expression values in colon cancer cell lines were normalized to that of Raji cells. All RT-PCR and flow cytometry assays were performed in duplicate. Gastroenterology 2005 129, 1047-1059DOI: (10.1053/j.gastro.2005.06.028) Copyright © 2005 American Gastroenterological Association Terms and Conditions